Skip to main content
Top

Angiogenesis

Issue 3/2016

Content (15 Articles)

Review Paper

HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies

Saima Subhani, Divya Teja Vavilala, Mridul Mukherji

Review Paper

ETS transcription factors in embryonic vascular development

Michael P. Craig, Saulius Sumanas

Review Paper

EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease

Du Yang, Chunna Jin, Hong Ma, Mingyuan Huang, Guo-Ping Shi, Jianan Wang, Meixiang Xiang

Original Paper

Quercitrin treatment protects endothelial progenitor cells from oxidative damage via inducing autophagy through extracellular signal-regulated kinase

Kangkang Zhi, Maoquan Li, Jun Bai, Yongfa Wu, Sili Zhou, Xiaoping Zhang, Lefeng Qu

Open Access Original Paper

CD34 expression modulates tube-forming capacity and barrier properties of peripheral blood-derived endothelial colony-forming cells (ECFCs)

Dimitar Tasev, Lara S. F. Konijnenberg, Joana Amado-Azevedo, Michiel H. van Wijhe, Pieter Koolwijk, Victor W. M. van Hinsbergh

Original Paper

VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue

Ernesta Fagiani, Pascal Lorentz, Ruben Bill, Kirusigan Pavotbawan, Lucie Kopfstein, Gerhard Christofori

Original Paper

mTORC2 mediates CXCL12-induced angiogenesis

Mary E. Ziegler, Michaela M. S. Hatch, Nan Wu, Steven A. Muawad, Christopher C. W. Hughes

Open Access Original Paper

Pigment epithelium-derived factor (PEDF): a novel trophoblast-derived factor limiting feto-placental angiogenesis in late pregnancy

Jelena Loegl, Erika Nussbaumer, Ursula Hiden, Alejandro Majali-Martinez, Nassim Ghaffari-Tabrizi-Wizy, Silvija Cvitic, Ingrid Lang, Gernot Desoye, Berthold Huppertz

Open Access Original Paper

Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes

Douglas A. MacDonald, Joel Martin, Kathir K. Muthusamy, Jiann-Kae Luo, Erica Pyles, Ashique Rafique, Tammy Huang, Terra Potocky, Yang Liu, Jingtai Cao, Françoise Bono, Nathalie Delesque, Pierre Savi, John Francis, Ali Amirkhosravi, Todd Meyer, Carmelo Romano, Meredith Glinka, George D. Yancopoulos, Neil Stahl, Stanley J. Wiegand, Nicholas Papadopoulos

Original Paper

Association of endothelial proliferation with the magnitude of weight loss during calorie restriction

Katarzyna Korybalska, Ewelina Swora-Cwynar, Joanna Łuczak, Alina Kanikowska, Natasza Czepulis, Rafał Rutkowski, Andrzej Bręborowicz, Marian Grzymisławski, Janusz Witowski

Original Paper

Circulating angiopoietin-2 levels in children and adolescents with type 1 diabetes mellitus: relation to carotid and aortic intima-media thickness

Mohamed Abo El-Asrar, Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, AlShaimaa Abo Bakr

Brief Communication

Vegfr3-CreER T2 mouse, a new genetic tool for targeting the lymphatic system

Ines Martinez-Corral, Lukas Stanczuk, Maike Frye, Maria Helena Ulvmar, Rodrigo Diéguez-Hurtado, David Olmeda, Taija Makinen, Sagrario Ortega

Erratum

Erratum to: Vegfr3-CreER T2 mouse, a new genetic tool for targeting the lymphatic system

Ines Martinez-Corral, Lukas Stanczuk, Maike Frye, Maria Helena Ulvmar, Rodrigo Diéguez-Hurtado, David Olmeda, Taija Makinen, Sagrario Ortega

Erratum

Erratum to: In situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization

Josef Ehling, Matthias Misiewicz, Saskia von Stillfried, Diana Möckel, Jessica Bzyl, Sibylle Pochon, Wiltrud Lederle, Ruth Knuechel, Twan Lammers, Moritz Palmowski, Fabian Kiessling

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.